Skip to main content

Market Overview

Perrigo Q2 Stock Plunges After Q2 Earnings Miss, Weak Cough/Cold Season

Perrigo Q2 Stock Plunges After Q2 Earnings Miss, Weak Cough/Cold Season
  • Perrigo Company plc (NYSE: PRGO) has posted Q2 sales of $981 million, an increase of 3.4% Y/Y, missing the consensus of $1.02 billion.
  • The sales growth was primarily due to an increase in most businesses and favorable currency movements, partially offset by Y/Y customer inventory reductions and a historically weak cough/cold season. Organic net sales growth was 0.5%.
  • Consumer Self-Care International Segment sales increased 11.7% to $359 million. Organic net sales grew 4.3%.
  • Consumer Self-Care Americas Segment reported sales of $622 million, down 0.9% Y/Y.
  • Adjusted operating income was $118 million, a decrease of 10.7%, due to higher operating expenses primarily to reinstate brand and marketing investments to pre-COVID-19 levels, lower volumes, unfavorable plant overhead absorption, higher input costs.
  • Adjusted diluted EPS of $0.50 declined from $0.59 in the prior-year quarter due primarily to reinstatement of brand and marketing investments. The consensus estimate was $0.62.
  • Outlook: Perrigo reaffirmed fiscal 2021 organic net sales growth outlook of 3% and expected adjusted diluted EPS towards the lower end of guidance of $2.50 - $2.70 (consensus $2.59).
  • Price Action: PRGO shares are down 11.70% at $43.44 on the last check Wednesday.

Related Articles (PRGO)

View Comments and Join the Discussion!

Posted-In: Earnings News Guidance Short Ideas Health Care Movers Trading Ideas General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at